BioCentury | May 6, 2017

mDx blueprint

Thanks to a well-planned robust pivotal trial and a dose of good timing, Cologuard from Exact Sciences Corp. is enjoying one of the steepest launch trajectories of any molecular diagnostic. After 10 quarters of sales,...
BC Innovations | Jun 25, 2009
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Colorectal cancer NDRG family member 4 (NDRG4) Studies in human tissues and in cell lines suggest that the tumor suppressor NDRG4 could be a marker...
Items per page:
1 - 2 of 2